Session » Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes II: Advances in Axial Spondyloarthritis (2633–2638)
- 3:00PM-3:15PM
-
Abstract Number: 2633
Comparative 3-year Safety Outcomes in Patients with Ankylosing Spondylitis Initiating JAK Inhibitor or TNF Inhibitor Therapy
- 3:15PM-3:30PM
-
Abstract Number: 2634
Sex differences in medication discontinuation in axial spondyloarthritis
- 3:30PM-3:45PM
-
Abstract Number: 2635
Differences in structural lesions of the spine between patients with early axSpA and non-axSpA chronic back pain: 2-year results of the SPACE Cohort
- 3:45PM-4:00PM
-
Abstract Number: 2636
Autoantibodies to 14-3-3 eta: A Novel Diagnostic Biomarker for Axial Spondyloarthritis
- 4:00PM-4:15PM
-
Abstract Number: 2637
Initial Phospholipid Transferase Activity Is Predictive of Five-Year Sacroiliac Radiographic Progression in Axial Spondyloarthritis: Findings From the DESIR Cohort
- 4:15PM-4:30PM
-
Abstract Number: 2638
ASembleNet: A Hybrid AI Model for MRI-Based Classification of Ankylosing Spondylitis